125 filings
S-8
PYPD
Polypid Ltd
6 Mar 24
Registration of securities for employees
4:28pm
20-F
2023 FY
PYPD
Polypid Ltd
Annual report (foreign)
6 Mar 24
4:05pm
6-K
PYPD
Polypid Ltd
14 Feb 24
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:16am
6-K
PYPD
Polypid Ltd
14 Feb 24
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
7:00am
EFFECT
PYPD
Polypid Ltd
14 Feb 24
Notice of effectiveness
12:15am
CORRESP
v86 h7apjb7dghvws
12 Feb 24
Correspondence with SEC
12:00am
UPLOAD
o9y8imi ktp40t154
9 Feb 24
Letter from SEC
12:00am
F-3
1g314n4x
1 Feb 24
Shelf registration (foreign)
5:26pm
D
9vpmj3ch5zegx
22 Jan 24
$35.01 mm in equity / options / securities to be acquired, sold $35.01 mm, 20 investors
8:00am
6-K
uhulss1c
5 Jan 24
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
9:28am
6-K
9tdq2s0dnuo7rv1
8 Nov 23
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:05am
6-K
k9p0e
7 Nov 23
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
7:05am
6-K
p2bu3oj
11 Oct 23
Report of Foreign Private Issuer
7:12am
6-K
eomg7
10 Oct 23
Report of Foreign Private Issuer
4:15pm
6-K
30qz9x6 51mcfrc5mb7
10 Oct 23
Report of Foreign Private Issuer
4:05pm
6-K
som1y
20 Sep 23
PolyPid Announces Reverse Share Split
9:21am
6-K
6doe8g2nlyyo82
18 Sep 23
Report of Foreign Private Issuer
8:00am
6-K
cpnbls
1 Sep 23
Notice of EXTRAORDINARY General Meeting of shareholders
4:02pm
6-K
e32 cihrvwlj
1 Sep 23
Notice of EXTRAORDINARY General Meeting of shareholders
4:00pm
6-K
r06438h
9 Aug 23
Report of Foreign Private Issuer
4:02pm